Lee's Pharmaceutical Holdings Limited
LPCUF
$0.185
-$0.0091-4.69%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 0.32% | -50.87% | 0.04% | 10,637.90% | 0.27% |
| Total Depreciation and Amortization | 0.32% | -58.95% | 0.04% | 133.05% | 0.13% |
| Total Amortization of Deferred Charges | 0.32% | -- | -- | -- | 0.13% |
| Total Other Non-Cash Items | 0.32% | 270.94% | -0.04% | -195.96% | 0.13% |
| Change in Net Operating Assets | -0.32% | -- | -- | -- | -0.13% |
| Cash from Operations | 0.32% | 211.09% | 0.04% | -17.03% | 0.13% |
| Capital Expenditure | -0.32% | -181.91% | -0.03% | 22.39% | -0.14% |
| Sale of Property, Plant, and Equipment | 0.00% | -- | -- | -- | 0.00% |
| Cash Acquisitions | -- | -- | -- | -- | 0.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -0.32% | -73.38% | -0.03% | -28.05% | -0.13% |
| Cash from Investing | -0.32% | -92.19% | -0.04% | -15.05% | -0.13% |
| Total Debt Issued | 0.00% | -- | -- | -- | 0.00% |
| Total Debt Repaid | 0.00% | -- | -- | -- | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.32% | -100.48% | -0.03% | -24.92% | -0.13% |
| Other Financing Activities | 0.00% | -200.00% | 0.00% | 227.25% | 0.00% |
| Cash from Financing | -0.32% | -207.25% | 0.04% | 483.07% | -0.13% |
| Foreign Exchange rate Adjustments | -0.39% | -234.06% | 0.00% | 238.90% | -0.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.32% | 12.23% | 0.04% | 286.87% | 0.13% |